QMENTA IMAGING
QMENTA is on a mission to help make brain diseases a thing of the past by using imaging to its full potential with computational analytics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 300 % | 400 % | - | - | 25 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (100 %) | (175 %) | 40 % | 5 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | - | 9 % | 3 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
QMENTA Imaging provides a comprehensive platform for managing medical imaging data in clinical trials. The platform is a global, secure, and compliant solution designed to aggregate, store, and process medical imaging data, aiming to enhance efficiency and enable collaboration among researchers and clinicians. The system features an imaging hub with an electronic data capture system to streamline imaging trials.
The company offers an AI Imaging Biomarkers Marketplace, which provides access to a catalog of AI-powered imaging analysis tools. This allows users to accelerate research, clinical studies, and diagnoses. The platform includes a user-friendly interface for handling imaging data and a multi-planar viewer for visualizing input, intermediate, and result imaging data. QMENTA also provides a special environment for neuroscience research users, known as the SDK, which allows for the development and deployment of custom analysis tools.
The business model appears to be centered around providing this platform as a service to organizations involved in clinical trials and medical research, such as pharmaceutical companies and contract research organizations. The company makes money by charging for access to its platform and the various tools and services it provides. The platform is designed to reduce the burden on clinical trial sites and ensure data quality through AI-powered solutions.
Keywords: medical imaging, clinical trials, AI, data management, biomarkers, neuroscience, platform, data analysis, cloud-based, healthcare